"Next Generation Sequencing-based Oncochip for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP"

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Breast Cancer, Metastatic Breast Cancer

Interventions

DRUG

Chemotherapy

in according to institutional guidelines

Trial Locations (1)

Istituto Europeo di Oncologia, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER